Literature DB >> 25758657

Patient-self assessment of flare in rheumatoid arthritis: translation and reliability of the Flare instrument.

Thomas Maribo1,2, Annette de Thurah3, Kristian Stengaard-Pedersen3.   

Abstract

The Flare instrument (FI) is a French self-administrated questionnaire used to identify flares in disease activity in patients with rheumatoid arthritis. In addition to a total score, the FI has two subscales: one relating to joint symptoms and one relating to general symptoms. The objective of this study was to translate and adapt the French FI into Danish and to determine the reliability of the FI in a consecutive cohort of patients with RA. The FI was translated according to international guidelines, tested among 10 patients and 5 health professionals, and adapted. Test-retest reliability was determined by the standard error of the measurement (SEM) and the intra class correlation coefficients (ICC). The FI was administered to 50 patients with rheumatoid arthritis from an outpatient clinic of a university hospital and re-administered after 10 days. The patients had a mean age of 65.3 years (SD 12.0) and mean disease duration of 18.1 years (range 2-47 years). We found an excellent reliability with ICC higher than 0.95 and SEM between 0.44 and 0.63. Best reliability was found in the total FI score. Thus, the results of the present study show that the FI is a feasible and reliable tool for evaluation of flares in patients with rheumatoid arthritis.

Entities:  

Keywords:  Flare; Flare instrument; Patient reported outcome measure; Questionnaire translation; Rheumatoid arthritis

Mesh:

Year:  2015        PMID: 25758657     DOI: 10.1007/s10067-014-2848-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  17 in total

1.  Measures of reliability in sports medicine and science.

Authors:  W G Hopkins
Journal:  Sports Med       Date:  2000-07       Impact factor: 11.136

2.  Starting at the beginning: an introduction to coefficient alpha and internal consistency.

Authors:  David L Streiner
Journal:  J Pers Assess       Date:  2003-02

3.  2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovsky; Frederick Wolfe; Gillian Hawker
Journal:  Ann Rheum Dis       Date:  2010-09       Impact factor: 19.103

4.  Quality criteria were proposed for measurement properties of health status questionnaires.

Authors:  Caroline B Terwee; Sandra D M Bot; Michael R de Boer; Daniëlle A W M van der Windt; Dirk L Knol; Joost Dekker; Lex M Bouter; Henrica C W de Vet
Journal:  J Clin Epidemiol       Date:  2006-08-24       Impact factor: 6.437

5.  Consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Authors:  J S Smolen; E C Keystone; P Emery; F C Breedveld; N Betteridge; G R Burmester; M Dougados; G Ferraccioli; U Jaeger; L Klareskog; T K Kvien; E Martin-Mola; K Pavelka
Journal:  Ann Rheum Dis       Date:  2006-10-26       Impact factor: 19.103

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

Review 7.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Authors:  F Guillemin; C Bombardier; D Beaton
Journal:  J Clin Epidemiol       Date:  1993-12       Impact factor: 6.437

8.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

9.  Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group).

Authors:  Clifton O Bingham; Christoph Pohl; Thasia G Woodworth; Sarah E Hewlett; James E May; Mahboob U Rahman; James P Witter; Daniel E Furst; C Vibeke Strand; Maarten Boers; Rieke E Alten
Journal:  J Rheumatol       Date:  2009-08-14       Impact factor: 4.666

10.  Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study.

Authors:  Tuulikki Sokka; Sergio Toloza; Maurizio Cutolo; Hannu Kautiainen; Heidi Makinen; Feride Gogus; Vlado Skakic; Humeira Badsha; Tõnu Peets; Asta Baranauskaite; Pál Géher; Ilona Ujfalussy; Fotini N Skopouli; Maria Mavrommati; Rieke Alten; Christof Pohl; Jean Sibilia; Andrea Stancati; Fausto Salaffi; Wojciech Romanowski; Danuta Zarowny-Wierzbinska; Dan Henrohn; Barry Bresnihan; Patricia Minnock; Lene Surland Knudsen; Johannes Wg Jacobs; Jaime Calvo-Alen; Juris Lazovskis; Geraldo da Rocha Castelar Pinheiro; Dmitry Karateev; Daina Andersone; Sylejman Rexhepi; Yusuf Yazici; Theodore Pincus
Journal:  Arthritis Res Ther       Date:  2009-01-14       Impact factor: 5.156

View more
  3 in total

1.  The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA).

Authors:  N Barroso; T G Woodworth; D E Furst; F Guillemin; B J Fautrel; N Borazan; S Kafaja; J Brook; D A Elashoff; V K Ranganath
Journal:  Clin Rheumatol       Date:  2019-09-06       Impact factor: 2.980

2.  The effect of an intensive smoking cessation intervention on disease activity in patients with rheumatoid arthritis: study protocol for a randomised controlled trial.

Authors:  Ida Kristiane Roelsgaard; Thordis Thomsen; Mikkel Østergaard; Robin Christensen; Merete Lund Hetland; Søren Jacobsen; Lena Andersen; Hanne Tønnesen; Silvia Rollefstad; Anne Grete Semb; Bente Appel Esbensen
Journal:  Trials       Date:  2017-11-28       Impact factor: 2.279

3.  AmbuFlex: tele-patient-reported outcomes (telePRO) as the basis for follow-up in chronic and malignant diseases.

Authors:  Liv Marit Valen Schougaard; Louise Pape Larsen; Anne Jessen; Per Sidenius; Liv Dorflinger; Annette de Thurah; Niels Henrik Hjollund
Journal:  Qual Life Res       Date:  2016-01-20       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.